• News Feeds
Page last updated at 07:13 GMT, Monday, 2 July 2012 08:13 UK

Should NHS spend more on new drugs?


The NHS is not spending enough on new drugs, according to the drugs industry.

Stephen Whitehead, chief executive of the Association of the British Pharmaceutical Industry, says the UK has the "lowest medicine prices in Europe but the slowest adoption of new medicines into the NHS".

Roy Lilley, an independent health policy analyst, told the Today programme that the reason the drugs bill is coming down is because the NHS has "gone out of its way to bring it down".

"It's a question of what is affordable," he explains, "the money has to be ploughed back into patient services."

Get in touch with Today via email , Twitter or Facebook or text us on 84844.


Story Tools


Sign in

BBC navigation

Copyright © 2018 BBC. The BBC is not responsible for the content of external sites. Read more.

This page is best viewed in an up-to-date web browser with style sheets (CSS) enabled. While you will be able to view the content of this page in your current browser, you will not be able to get the full visual experience. Please consider upgrading your browser software or enabling style sheets (CSS) if you are able to do so.

Americas Africa Europe Middle East South Asia Asia Pacific